Biocon advanced 3.17% to Rs 328.75 after Biocon Biologics (BBL) secures multiple market access agreements in the United States for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab), ...

Cigna raised its full-year profit forecast after outperforming expectations in Q1, largely thanks to its pharmacy benefit ...

Merck's $3.9B SpringWorks deal, Hims & Hers' Wegovy partnership, CVS exiting Obamacare, and FDA updates on key drugs.

The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...

The health sector faces a tumultuous period as the U.S. government proposes budget cuts impacting key research institutions, ...

Hartford- based Aetna plans to pull out of Affordable Care Act health-insurance exchanges nationwide next year, parent company CVS Health announced on Thursday. "We're disappointed by the continued ...

Cigna Group on Friday reported a $1.3 billion profit for the first quarter of 2025, a sharp turnaround from a year-earlier ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

Aetna is a minor player in the health insurance exchange market, and the exchanges are a small segment of the CVS Health ...

CVS will exit Obamacare plans in 2026, affecting 1 million members across 17 states, and close stores amid pharmacy desert ...

The global health insurance market size is predicted to increase from USD 2,710 billion in 2025 and is projected to be worth ...

CVS Health Corp. reported a strong start to 2025, with first-quarter revenue climbing 7%, driven by growth across all ...